Meadowside Residential Care Home is a limited company operating in the fields of healthcare, specifically focused on providing specialized residential care services for individuals experiencing growth hormone deficiency and related conditions. Established in 2012, the company’s registered number is 07972592 and maintains an active status. Located at Units 7 - 8 Manor Courtyard, Aylesbury, HP17 8JB, we serve clients across Buckinghamshire and surrounding areas within the United Kingdom. Our core service revolves around GENOTROPIN® (somatropin) – a FDA-approved prescription growth hormone therapy utilized for children and adults with specific growth disorders. We offer comprehensive support, including monitoring of physiological parameters, nutritional management, and therapeutic interventions designed to optimize patient well-being. The company’s strategic focus is on continued expansion within the healthcare sector. While international presence is currently not established, we are actively pursuing opportunities to enhance our services through partnerships and collaborations with specialists in endocrinology and pediatric medicine. We operate under a Skilled Worker visa program, holding a worker rating of A. Our business model prioritizes client-centered care and ongoing research into innovative therapies.

Meadowside Residential Care Home is a limited company operating in the fields of healthcare, specifically focused on providing specialized residential care services for individuals experiencing growth hormone deficiency and related conditions. Established in 2012, the company’s registered number is 07972592 and maintains an active status. Located at Units 7 - 8 Manor Courtyard, Aylesbury, HP17 8JB, we serve clients across Buckinghamshire and surrounding areas within the United Kingdom. Our core service revolves around GENOTROPIN® (somatropin) – a FDA-approved prescription growth hormone therapy utilized for children and adults with specific growth disorders. We offer comprehensive support, including monitoring of physiological parameters, nutritional management, and therapeutic interventions designed to optimize patient well-being. The company’s strategic focus is on continued expansion within the healthcare sector. While international presence is currently not established, we are actively pursuing opportunities to enhance our services through partnerships and collaborations with specialists in endocrinology and pediatric medicine. We operate under a Skilled Worker visa program, holding a worker rating of A. Our business model prioritizes client-centered care and ongoing research into innovative therapies.